John C. Aplin is Director at ENDOCYTE INC (ECYT). They have made 1 open-market trade across 1 company since 2011, most recently 2018-12-21.
CIK 0001033188
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $65K since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ECYT | 32,163 | $772K |
Shares reported on the most recent Form 4, priced at the 2018-05-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ECYT | BUY | 2011-12-16 | 2011-12-16 | $3.27 | $65K | -24.6% | -0.5% | -0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.